Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$4,656,285
-$132,294 QoQ
Shares Held
18,334
-6.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#1,670
of 4,664 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Everhart Financial Group, Inc. holds $28,655,287 across 10 Drug Manufacturers - General names. JNJ ranks #3 (16.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,990 | $9,583,446 | |
| 2 | ABBV |
AbbVie Inc.
|
25,328 | $6,373,537 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
18,334 | $4,656,285 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,484 | $2,503,694 | |
| 5 | AMGN |
Amgen Inc
|
5,085 | $1,841,380 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
9,646 | $1,218,675 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
21,040 | $1,212,324 | |
| 8 | PFE |
Pfizer Inc
|
27,433 | $660,586 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,656,285 | 18,334 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $4,788,579 | 19,590 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $3,101,973 | 14,989 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $2,526,162 | 13,624 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,894,252 | 12,401 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,772,995 | 10,691 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $876,831 | 6,063 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,584,136 | 9,775 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,148,232 | 7,856 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,400,297 | 8,852 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,077,117 | 6,872 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,523,858 | 9,784 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $1,523,942 | 9,207 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,322,460 | 8,532 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $1,610,694 | 9,118 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,384,966 | 8,478 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $1,512,562 | 8,521 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $1,293,601 | 7,299 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $957,478 | 5,597 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $838,508 | 5,192 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $835,890 | 5,074 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $437,664 | 2,663 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $417,371 | 2,652 | Shares | Sole | 2021-03-26 | |
| No filing history on record for this holder in this stock. | ||||||